ATLANTA, June 08, 2026 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Grail, Inc. (“Grail”) (NASDAQ: GRAL). The lawsuit alleges that Defendants made false and misleading statements and/or failed to disclose material adverse facts regarding the probability of achieving the primary endpoint of a statistically significant reduction in Stage III-IV cancers in Grail’s NHS-Galleri trial.
If you purchased Grail shares between May 13, 2025 and February 19, 2026, and experienced a loss on that investment, you are encouraged to discuss your legal rights by contacting Marshall P. Dees, Esq. at mdees@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/grail/ for more information.
The deadline to ask the court to be appointed lead plaintiff in the case is August 4, 2026.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Marshall P. Dees, Esq.
(888) 508-6832 (toll-free)
mdees@holzerlaw.com
